RET receptor tyrosine kinase gene mutations: molecular biological, physiological and clinical aspects
- 1 August 1996
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 26 (8), 613-624
- https://doi.org/10.1111/j.1365-2362.1996.tb02144.x
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Loss of function effect of RET mutations causing Hirschsprung diseaseNature Genetics, 1995
- RET proto-oncogene mutations in French MEN 2A and FMTC familiesHuman Molecular Genetics, 1994
- Growth factor signaling by receptor tyrosine kinasesNeuron, 1992
- Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2AGenomics, 1991
- Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10Genomics, 1989
- Expression of proto-ret mRNA in embryonic and adult rat tissuesBiochemical and Biophysical Research Communications, 1988
- The Clinical Outcome of Prospective Screening for Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1988
- Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entityBritish Journal of Surgery, 1986
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971
- A simple analysis for normetanephrine and metanephrine in urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1960